Clinically compatible advances in blood-derived endothelial progenitor cell isolation and reprogramming for translational applications
About the Speaker
Dr Amer Rana has been working in the field of developmental biology and its application to medicine and therapeutics for over 20 years. He obtained his PhD at the National Institute for Medical Research, Mill, Hill, London after which undertook his postdoctoral training at the Gurdon Institute in Cambridge, UK. In 2010, he was awarded the British Heart Foundation Lectureship in Regenerative Medicine and set up his lab in the Department of Medicine, University of Cambridge based in Addenbrooke’s Hospital. The was also awarded the Pfizer European Young Researcher of the Year in the same year. Recently he moved to the University of East Anglia, where he is the Director of the Biomedical Research Centre and Associate Professor in Biomedicine. His labs’ focus is to elucidate important mechanisms regulating the pathobiology of cardiovascular and ardiopulmonary diseases and to develop new drug and cellular therapies to treat this. As a apart of this work Dr Rana has established a long standing collaboration with Reprocell to clinically translate endothelial progenitor cell derived iPSCs.